MedPath
HSA Approval

BISOCOR TABLET 2.5MG

SIN15805P

BISOCOR TABLET 2.5MG

BISOCOR TABLET 2.5MG

September 12, 2019

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C07AB07

bisoprolol

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. INDUSTRIES (M) SDN. BHD.

Active Ingredients

BISOPROLOL FUMARATE

2.5mg

Bisoprolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BISOCOR TABLET 2.5MG - HSA Approval | MedPath